Valuation: 10x Genomics, Inc.

Market Cap 6.08B 5.26B 4.91B 4.51B 8.52B 578B 8.61B 57.65B 22.63B 289B 22.82B 22.32B 957B P/E 2026 *
-59x
P/E 2027 * -68.5x
Enterprise Value 5.6B 4.85B 4.52B 4.16B 7.85B 532B 7.93B 53.11B 20.84B 266B 21.02B 20.56B 882B EV / Sales 2026 *
9.12x
EV / Sales 2027 * 8.23x
Free-Float
90.53%
Yield 2026 *
-
Yield 2027 * -
1 day-0.84%
1 week+0.87%
Current month+0.40%
1 month+21.66%
3 months+119.21%
6 months+149.00%
Current year+190.99%
1 week 45.21
Extreme 45.21
50.34
1 month 35.12
Extreme 35.12
50.34
Current year 15.9
Extreme 15.9
50.34
1 year 11.16
Extreme 11.16
50.34
3 years 6.78
Extreme 6.78
57.9
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
2/26/26 Free

Founder

88,816 0.0763%
2/26/26 Free

Chief Financial Officer

106,579 0.0915%
2/26/26 Free

Founder

157,895 0.1356%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%+0.87%+246.93%-15.31% 6.08B
+2.12%+13.62%+269.27%+331.46% 21.44B
-0.96%-4.07%-42.71%-23.96% 9.84B
+0.39%-1.11%+42.04%+34.10% 6.58B
-0.73%-2.29%-15.70%-17.24% 5.46B
+2.17%+5.52%-44.22% - 4.55B
0.00%+6.09%-11.86%-21.30% 4.55B
+3.55%+3.97%+78.19%+95.98% 4.18B
-2.68%+2.32%-19.24%-38.03% 2.84B
-0.77%+3.43%-31.78%-14.33% 1.32B
Average +0.23%+2.23%+47.09%+36.82% 6.68B
Weighted average by Cap. +0.68%+4.04%+105.03%+113.77%

Financials

2026 *2027 *
Net sales 614M 532M 496M 456M 861M 58.39B 870M 5.83B 2.29B 29.21B 2.31B 2.26B 96.76B 671M 582M 542M 499M 941M 63.85B 952M 6.37B 2.5B 31.95B 2.52B 2.47B 106B
Net income -104M -90.48M -84.34M -77.57M -146M -9.93B -148M -991M -389M -4.97B -392M -384M -16.46B -90.68M -78.54M -73.21M -67.34M -127M -8.62B -129M -860M -338M -4.31B -341M -333M -14.29B
Net Debt -478M -414M -386M -355M -671M -45.48B -678M -4.54B -1.78B -22.76B -1.8B -1.76B -75.37B -548M -475M -442M -407M -768M -52.11B -777M -5.2B -2.04B -26.07B -2.06B -2.01B -86.35B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-08-05 US$47.46 -0.84% 2,479,658
26-08-04 US$47.86 +1.81% 2,655,384
26-08-03 US$47.01 -0.55% 3,397,348
26-07-31 US$47.27 -4.37% 2,869,326
26-07-30 US$49.43 +6.71% 2,259,737
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
47.46USD
Average target price
41.54USD
Spread / Average Target
-12.48%

Quarterly revenue - Rate of surprise